Codice QR

A Preliminary Study Examining the Correlation between EGFRI Treatment, Clinic Dermatoscopy Features, and Serum Levels of Anti-Alpha-Galactosyl IgE in Colorectal Cancer Patients

The introduction of molecularly targeted therapies, particularly the epidermal growth factor receptor inhibitors (EGFRIs), has had a positive impact by increasing the life expectancy of patients with advanced colorectal cancer (CRC). The most used anti-EGFRIs monoclonal antagonist, Cetuximab, induce...

Descrizione completa

Salvato in:
Autori principali: Cristina Maria Popa, Irina Florina Cherciu Harbiyeli, Ana Maria Ciurea, Irina Mihaela Cazacu, Simona Laura Ianosi, Michael Schenker, Adrian Saftoiu
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2024-06-01
Serie:Gastroenterology Insights
Soggetti:
colorectal cancer
skin toxicity
EGFRI
alpha-galactosyl
dermatoscopy
anti-alpha-galactosyl IgE
Accesso online:https://www.mdpi.com/2036-7422/15/2/37
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi